Potentiation of estrogen receptor activation function 1 (AF-1) by Src/JNK through a serine 118-independent pathway

被引:105
作者
Feng, WJ
Webb, P
Nguyen, P
Liu, XH
Li, JD
Karin, M
Kushner, PJ [1 ]
机构
[1] Univ Calif San Francisco, Metab Res Unit 1119 HSW, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA
[3] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA
关键词
D O I
10.1210/me.15.1.32
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Estrogen receptor (ER) is activated either by ligand or by signals from tyrosine kinase-linked cell surface receptors. We investigated whether the nonreceptor Src tyrosine kinase could affect 88 activity. Expression of constitutively active Src or stimulation of the endogenous Src/JNK pathway enhances transcriptional activation by the estrogen-ER complex and strongly stimulates the otherwise weak activation by the unliganded ER and the tamoxifen-ER complex. Src affects ER activation function 1 (AF-1), and not ER AF-2, and does so through its tyrosine kinase activity. This effect of Src is mediated partly through a Raf/mitogen-activated ERK kinase/extracellular signal-regulated kinase (Raf/MEK/ERK) signaling cascade and partly through a MEKK/JNKK/JNK cascade. Although, as previously shown, Src action through activated ERK stimulates AF-1 by phosphorylation at S118, Src action through activated JNK neither leads to phosphorylation of S118 nor requires S118 for its action. We therefore suggest that the Src/JNK pathway enhances AF-1 activity by modification of ER AF-1-associated proteins. Src potentiates activation functions in CREB-binding protein (CBP) and glucocorticoid receptor interacting protein 1 (GRIP1), and we discuss the possibility that the Src/JNK pathway enhances the activity of these coactivators, which are known to mediate AF-1 action.
引用
收藏
页码:32 / 45
页数:14
相关论文
共 88 条
  • [1] PD-098059 IS A SPECIFIC INHIBITOR OF THE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE KINASE IN-VITRO AND IN-VIVO
    ALESSI, DR
    CUENDA, A
    COHEN, P
    DUDLEY, DT
    SALTIEL, AR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) : 27489 - 27494
  • [2] MODULATION OF TRANSCRIPTIONAL ACTIVATION BY LIGAND-DEPENDENT PHOSPHORYLATION OF THE HUMAN ESTROGEN RECEPTOR-A/B REGION
    ALI, S
    METZGER, D
    BORNERT, JM
    CHAMBON, P
    [J]. EMBO JOURNAL, 1993, 12 (03) : 1153 - 1160
  • [3] AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer
    Anzick, SL
    Kononen, J
    Walker, RL
    Azorsa, DO
    Tanner, MM
    Guan, XY
    Sauter, G
    Kallioniemi, OP
    Trent, JM
    Meltzer, PS
    [J]. SCIENCE, 1997, 277 (5328) : 965 - 968
  • [4] Estradiol-binding mechanism and binding capacity of the human estrogen receptor is regulated by tyrosine phosphorylation
    Arnold, SF
    Melamed, M
    Vorojeikina, DP
    Notides, AC
    Sasson, S
    [J]. MOLECULAR ENDOCRINOLOGY, 1997, 11 (01) : 48 - 53
  • [5] ARNOLD SF, 1995, J BIOL CHEM, V270, P30205
  • [6] AURICCHIO F, 1995, CELL GROWTH DIFFER, V6, P105
  • [7] The CBP co-activator is a histone acetyltransferase
    Bannister, AJ
    Kouzarides, T
    [J]. NATURE, 1996, 384 (6610) : 641 - 643
  • [8] ROLE OF THE 2 ACTIVATING DOMAINS OF THE ESTROGEN-RECEPTOR IN THE CELL-TYPE AND PROMOTER-CONTEXT DEPENDENT AGONISTIC ACTIVITY OF THE ANTIESTROGEN 4-HYDROXYTAMOXIFEN
    BERRY, M
    METZGER, D
    CHAMBON, P
    [J]. EMBO JOURNAL, 1990, 9 (09) : 2811 - 2818
  • [9] ESTRADIOL MEMBRANE-BINDING SITES ON HUMAN-BREAST CANCER CELL-LINES - USE OF A FLUORESCENT ESTRADIOL CONJUGATE TO DEMONSTRATE PLASMA-MEMBRANE BINDING SYSTEMS
    BERTHOIS, Y
    POURREAUSCHNEIDER, N
    GANDILHON, P
    MITTRE, H
    TUBIANA, N
    MARTIN, PM
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1986, 25 (06) : 963 - 972
  • [10] L-selectin activates JNK via src-like tyrosine kinases and the small G-protein Rac
    Brenner, B
    Weinmann, S
    Grassme, H
    Lang, F
    Linderkamp, O
    Gulbins, E
    [J]. IMMUNOLOGY, 1997, 92 (02) : 214 - 219